StockData
Kronos Worldwide Inc logo

Kronos Worldwide Inc (KRO) stock analysis

KRONYSEIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30135% above fair value
$8.50+0.28 (+3.41%)

Close on Nov 11, 2026Market cap $978.33MP/E –Yield 2.35%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth1Performance0Health2Dividend1

Weak4 of 30 checks passed

Kronos Worldwide passes 4 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
0/6
Financial health
2/6
Dividend
1/6

What stands out

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 27.2% of total debt.

  • Growing faster than the industry

    Revenue grew 8.7% over the last twelve months; the Chemicals and Allied Products median is 8.2%.

  • Short-term assets cover short-term debts

    Current assets are 3.30 times current liabilities.

  • Pays a dividend

    Kronos Worldwide paid dividends worth 2.4% of the share price over the last twelve months.

What to watch

  • Margin of safety under 20%

    The price is 135% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $8.50 is above our fair value estimate of $3.61.

  • Return on equity under 15%

    Return on equity was -4.7% over the last twelve months and averaged 3.2% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 2.6%, below the 10% that usually covers the cost of capital.

Valuation0/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA above its 5-year median

    Kronos Worldwide's EV/EBITDA of 33.0 is above its 5-year median of 11.3.

  • P/B above the industry

    Kronos Worldwide's price-to-book of 1.25 is above the Chemicals and Allied Products median of 1.25.

  • Trading above fair value

    The share price of $8.50 is above our fair value estimate of $3.61.

  • Margin of safety under 20%

    The price is 135% above fair value, so there is no margin of safety.

Growth1/6
  • Revenue growing under 10% a year

    Revenue grew -1.2% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 8.7% over the last twelve months; the Chemicals and Allied Products median is 8.2%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin slipping

    Gross margin was 15.3% over the last twelve months, against 16.3% a year earlier.

Past performance0/6
  • Return on equity under 15%

    Return on equity was -4.7% over the last twelve months and averaged 3.2% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 2.6%, below the 10% that usually covers the cost of capital.

  • Return on equity below the industry

    Kronos Worldwide's return on equity of -4.7% is below the Chemicals and Allied Products median of -0.8%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was -1.9% over the last twelve months, against a 5-year average of 1.4%.

  • Net margin below the industry

    Kronos Worldwide's net margin of -1.9% is below the Chemicals and Allied Products median of -0.4%.

Financial health2/6
  • High debt

    Debt is 68.9% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 61.2% five years ago to 68.9%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 27.2% of total debt.

  • Interest not well covered

    Operating income covers interest expense 0.8 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 3.30 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.06; above 3 is the safe zone and below 1.8 the distress zone.

Dividend1/6
  • Pays a dividend

    Kronos Worldwide paid dividends worth 2.4% of the share price over the last twelve months.

  • Yield below Treasuries

    The 2.4% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Kronos Worldwide yields 2.4%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Earnings cover

    Needs dividends paid and net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$3.61

The share price is 135% above this estimate.

20%+ below
Near fair value
20%+ above
$8.50Price$3.61Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
EV/EBITDA17.1×11.3×21.4×$2.2778%
P/B1.2×1.2×1.2×$8.3222%
Fair value$3.61100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$2.58M
Value traded per 1% price move
$1.34M

Downside

Medium risk

Typical loss in a bad month
17.6%
Volatility (annualized)
61%
Sharpe ratio, 1 year
1.29
Beta to the S&P 500 (5Y)
1.19

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

11.5%−10.0 pts over 5 years

Operating margin

-2.0%−9.1 pts over 5 years

Net margin

-6.0%−9.9 pts over 5 years

See a number that looks wrong?